1. Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment
- Author
-
Cheng Chen, Melissa H Roberts, Dennis W Raisch, Todd A Thompson, Amy Bachyrycz, and Matthew E Borrego
- Subjects
Adult ,Pharmacology ,Drug-Related Side Effects and Adverse Reactions ,Pharmacogenetics ,Polypharmacy ,Humans ,Molecular Medicine ,General Medicine ,Confidentiality ,Pharmacogenomic Testing - Abstract
Aim: To elicit preferences for pharmacogenomic (PGx) testing in polypharmacy patients. Materials & methods: A face-to-face discrete choice experiment survey was designed and administered to adult polypharmacy patients recruited at a local retail pharmacy in Albuquerque (NM, USA). Results: A total of 128 eligible polypharmacy patients completed the discrete choice experiment survey and significantly preferred a PGx test with lower cost, better confidentiality and higher certainty of identifying best medication/dose and side effects and one that can be used to advocate for their treatment needs (all p
- Published
- 2022